Novocell clinical trials
Acquired by Vertex Pharmaceuticals Incorporated, Sep 27, 2022 · source ↗
The registry lists 1 studies whose lead sponsor is Novocell. 0 are recruiting or about to start. Per ClinicalTrials.gov, last updated Sep 9, 2014.
Before and after it joined Vertex Pharmaceuticals Incorporated
- First submitted before Novocell became part of Vertex Pharmaceuticals Incorporated
- 1
- First submitted after Novocell became part of Vertex Pharmaceuticals Incorporated
- 0
- Unclear, or no submission date
- 0
By the date each study was first submitted to the registry. The registry lists today's sponsor name and keeps no history, so this says when a study was filed, not who filed it.
Registry sponsor names on this page
- Novocell1 study
Something wrong with this grouping? Tell us on the Vertex Pharmaceuticals Incorporated page.
Studies
Recruiting first, then most recently updated. Showing 1 of 1. All Vertex Pharmaceuticals Incorporated studies →
- Safety and Efficacy of PEG-Encapsulated Islet Allografts Implanted in Type I Diabetic RecipientsTerminatedNCT00260234Phase 1/2
Sponsor listed in the registry: Novocell · First submitted before Novocell became part of Vertex Pharmaceuticals Incorporated